Absolute Return Capital’s Bristol-Myers Squibb BMY Stock Holding History

Absolute Return Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-52,108	Closed	-$2.67M	–	639
2014 Q3	$2.67M	Sell	52,108 -15,041	-22%	-$751K	0.04%	393
2014 Q2	$3.26M	Sell	67,149 -19,920	-23%	-$982K	0.04%	464
2014 Q1	$4.52M	Sell	87,069 -50,289	-37%	-$2.68M	0.07%	334
2013 Q4	$7.3M	Sell	137,358 -485,141	-78%	-$24.7M	0.08%	281
2013 Q3	$28.8M	Sell	622,499 -225,893	-27%	-$9.92M	0.4%	76
2013 Q2	$37.9M	Buy	+848,392	New	+$36.8M	0.49%	47

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Absolute Return Capital's BMY Position: Q4 2014 in Review

Absolute Return Capital sold out of Bristol-Myers Squibb (BMY) in Q4 2014, closing a stake of 52,108 shares — an estimated $2.67M sold.

Absolute Return Capital first reported a position in BMY in Q2 2013 and held it in 6 quarters. The position peaked at $37.9M in Q2 2013. 1,409 funds tracked by Wall St. Rank hold BMY as of Q4 2014.

Absolute Return Capital reported no remaining Bristol-Myers Squibb position as of Q4 2014 after selling out during the quarter.
Absolute Return Capital sold 52,108 Bristol-Myers Squibb shares in Q4 2014, an estimated $2.67M.
Absolute Return Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 6 quarters.
Absolute Return Capital's Bristol-Myers Squibb position peaked at $37.9M in Q2 2013.
1,409 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2014.

Based on Absolute Return Capital's 13F filing for Q4 2014, filed 17 Feb 2015.